This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,788.22 firm fixed-price delivery order is for the supply of DALIRESP 500 MCG TABLET 30S, with a period of performance through December 3, 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These contracts enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
The contract award does not have a set-aside designation, indicating open competition. As a major distributor of medical products to federal agencies, AmerisourceBergen plays a critical role in supplying pharmaceuticals, vaccines, and other medical supplies to military treatment facilities, veterans' healthcare programs, and other government medical institutions.
Generated 3/9/25, 1:00 AM